Nanalysis Scientific Statistics

Total Valuation

Nanalysis Scientific has a market cap or net worth of CAD 35.06 million. The enterprise value is 52.48 million.

Market Cap	35.06M
Enterprise Value	52.48M

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Nanalysis Scientific has 113.10 million shares outstanding. The number of shares has increased by 10.64% in one year.

Current Share Class	n/a
Shares Outstanding	113.10M
Shares Change (YoY)	+10.64%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	4.48%
Owned by Institutions (%)	0.03%
Float	105.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.78
PB Ratio	1.55
P/TBV Ratio	2.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.34
EV / Sales	1.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-101.91

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.78.

Current Ratio	1.30
Quick Ratio	0.82
Debt / Equity	0.78
Debt / EBITDA	n/a
Debt / FCF	-34.26
Interest Coverage	-5.29

Financial Efficiency

Return on equity (ROE) is -34.55% and return on invested capital (ROIC) is -8.65%.

Return on Equity (ROE)	-34.55%
Return on Assets (ROA)	-7.09%
Return on Capital (ROIC)	-8.65%
Revenue Per Employee	172,715
Profits Per Employee	-33,269
Employee Count	249
Asset Turnover	0.84
Inventory Turnover	5.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.48% in the last 52 weeks. The beta is 0.65, so Nanalysis Scientific's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-19.48%
50-Day Moving Average	0.34
200-Day Moving Average	0.39
Relative Strength Index (RSI)	49.38
Average Volume (20 Days)	171,459

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nanalysis Scientific had revenue of CAD 43.01 million and -8.28 million in losses. Loss per share was -0.08.

Revenue	43.01M
Gross Profit	10.28M
Operating Income	-5.79M
Pretax Income	-7.30M
Net Income	-8.28M
EBITDA	-8.26M
EBIT	-5.79M
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

The company has 223,000 in cash and 17.64 million in debt, giving a net cash position of -17.42 million or -0.15 per share.

Cash & Cash Equivalents	223,000
Total Debt	17.64M
Net Cash	-17.42M
Net Cash Per Share	-0.15
Equity (Book Value)	22.56M
Book Value Per Share	0.20
Working Capital	3.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -348,000 and capital expenditures -167,000, giving a free cash flow of -515,000.

Operating Cash Flow	-348,000
Capital Expenditures	-167,000
Free Cash Flow	-515,000
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 23.90%, with operating and profit margins of -13.47% and -19.26%.

Gross Margin	23.90%
Operating Margin	-13.47%
Pretax Margin	-16.97%
Profit Margin	-19.26%
EBITDA Margin	-19.21%
EBIT Margin	-13.47%
FCF Margin	n/a

Dividends & Yields

Nanalysis Scientific does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.64%
Shareholder Yield	-10.64%
Earnings Yield	-25.99%
FCF Yield	-1.47%

Stock Splits

The last stock split was on June 13, 2019. It was a reverse split with a ratio of 0.25.

Last Split Date	Jun 13, 2019
Split Type	Reverse
Split Ratio	0.25

Scores

Nanalysis Scientific has an Altman Z-Score of 0.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.44
Piotroski F-Score	n/a